Labat Africa (JSE:LAB) Total Liabilities: R456.0 Mil (As of Nov. 2025)


What is Labat Africa Total Liabilities?

Labat Africa JSE:LAB +66.67% Total Liabilities is R456.0 Mil as of Nov. 2025. The stock has 5 warning signs investors should review.

Labat Africa's Total Liabilities for the quarter that ended in Nov. 2025 was R456.0 Mil.

Labat Africa's quarterly Total Liabilities increased from Nov. 2024 (R145.50 Mil) to May. 2025 (R428.11 Mil) and increased from May. 2025 (R428.11 Mil) to Nov. 2025 (R456.03 Mil).

Labat Africa's annual Total Liabilities increased from Aug. 2021 (R121.26 Mil) to May. 2023 (R123.15 Mil) and increased from May. 2023 (R123.15 Mil) to May. 2024 (R142.85 Mil).

Labat Africa Total Liabilities Historical Data

* Premium members only.

The historical data trend for Labat Africa's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labat Africa Total Liabilities Chart

Labat Africa Annual Data
Trend Feb14 Feb15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 May23 May24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 230.97 113.92 121.26 123.15 142.85

Labat Africa Semi-Annual Data
Aug15 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.72 142.85 145.50 428.11 456.03

Labat Africa Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Labat Africa's Total Liabilities for the fiscal year that ended in May. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=93.627+(6.484+42.735
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=142.8

Total Liabilities=Total Assets (A: May. 2024 )-Total Equity (A: May. 2024 )
=123.393--19.453
=142.8

Labat Africa's Total Liabilities for the quarter that ended in Nov. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=426.557+(9.101+20.373
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=456.0

Total Liabilities=Total Assets (Q: Nov. 2025 )-Total Equity (Q: Nov. 2025 )
=769.824-313.793
=456.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of R456.0 Mil mean?
Labat Africa (JSE:LAB) has a Total Liabilities of R456.0 Mil as of Nov. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Labat Africa and its competitors.
Is Labat Africa's Total Liabilities too high?
Labat Africa's current Total Liabilities is R456.0 Mil.
How does Labat Africa's Total Liabilities compare to ZTS and UTHR?
Labat Africa's Total Liabilities of R456.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Labat Africa and its competitors. Labat Africa's current Total Liabilities is R456.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current Total Liabilities is R456.0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current Total Liabilities is R456.0 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Labat Africa Business Description

Other Exchanges LAO:Germany
Address 75 Maude StreetSandown, The Leonardo 14th Floor, Sandown, Johannesburg, GT, ZAF, 1709
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.